(1)
BODY MASS INDEX (BMI) AND ITS ASSOCIATION WITH RISK FOR DEVELOPMENT OF CARDIOVASCULAR EVENTS. Journal of Pharmaceutical Negative Results 2022, 13 (4), 870-874.